Cargando…

The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis

Neurodegenerative movement disorders mainly include Parkinson’s disease, atypical parkinsonisms, Huntington disease, and hereditary ataxia. Riluzole is the only drug approved by the US Food and Drug Administration for amyotrophic lateral sclerosis. The neuroprotective effects of riluzole have been o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Wang, Lu-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058579/
https://www.ncbi.nlm.nih.gov/pubmed/29226728
http://dx.doi.org/10.1080/10717544.2017.1413446